Long-lived families reveal a rare genetic clue to healthy aging
Researchers at Leiden University Medical Center are moving closer to understanding why some families stay healthy longer than others. While life expectancy has climbed over the last two centuries, the time individuals spend free from chronic disease has not kept pace. A recent study presented at the European Society of Human Genetics conference highlights that focusing on entire long-lived families provides a sharper view of biological mechanisms than studying individuals in isolation.
The team analyzed 212 groups of siblings from the Leiden Longevity Study to isolate specific genetic regions linked to survival. By comparing the genomes of these families, investigators narrowed their search from 20,000 genes down to just 350. Further analysis identified 12 rare protein-altering variants that likely contribute to extended healthspan. One standout discovery involves the CGAS gene, which regulates the body's inflammatory response to cellular damage.
Pasquale Putter, who led the research, suggests that members of these long-lived families may possess a genetic variant that lowers their inflammatory response. This modification allows the body to repair damage and fight infections without triggering the chronic, low-level inflammation often associated with aging. By maintaining this balance, the body avoids the long-term tissue damage that leads to age-related illnesses.
The team is now taking these findings from the lab bench to live organisms. By introducing the CGAS mutation into killifish at the Max Planck Institute, they aim to see if these findings translate into longer, healthier lives in a controlled model. Because killifish have a short lifespan, they provide a fast track for researchers to observe the effects of these genetic markers in real time. This work offers a path toward potential future interventions designed to preserve health for as long as possible.
While the results are promising, the researchers maintain a cautious outlook. The CGAS pathway is complex, and completely inhibiting it carries risks, such as increased vulnerability to infection. Understanding how to modulate this gene without compromising the immune system is the next major hurdle for the team. These findings represent a significant step in moving beyond simple observation to identifying the actual biological drivers of a longer, disease-free life.